Country: Իտալիա
language: անգլերեն
source: HMA (Heads of Medicines Agencies)
carprofen 50 mg
Sogeval
QM01AE91
Tablet
carprofen
Dogs
2010-01-06
VETERINARY MEDICINAL PRODUCT DOLAGIS 50 MG TABLETS FOR DOGS PART I B SUMMARY OF PRODUCT CHARACTERISTICS PHARMACEUTICAL FORM TABLET 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DOLAGIS 50 mg tablets for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: One tablet contains: Carprofen ................................................................... 50 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet Clover-shaped scored beige tablet The tablet can be divided into four equal parts. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In the dog: Reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease. As a follow-up to parenteral analgesia in the management of post-operative pain. 4.3 CONTRAINDICATIONS Do not use in pregnant and lactating bitches. Do not use in dogs aged less than 4 months in the absence of specific data. Do not use in cats. Do not use in dogs, suffering from cardiac, hepatic or renal disease, when there is a possibility of gastrointestinal ulceration or bleeding or where there is evidence of blood dyscrasia. Do not use in case of hypersensitivity to the active substance, to other NSAIDs and to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES See sections 4.3 and 4.5. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use in dogs less than 6 weeks of age, or in aged dogs, may involve additional risk. If such a use cannot be avoided, dogs may require a reduced dosage and careful clinical manage read_full_document